Dissecting the damaging versus regenerative roles of CNS macrophages: Implications for the use of immunomodulatory therapeutics

Regenerative Medicine

Volumn 8, Issue 6, 2013, Pages 673-676

  Miron, Veronique E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

alternative activation; central nervous system; damage; M2 macrophage; macrophage; microglia; multiple sclerosis; regeneration; therapeutics

Indexed keywords

FINGOLIMOD; GLATIRAMER;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; IMMUNOMODULATION; MACROPHAGE; MACROPHAGE ACTIVATION; MICROGLIA; MULTIPLE SCLEROSIS; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; T LYMPHOCYTE; WHITE MATTER;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; IMMUNOMODULATION; MACROPHAGE ACTIVATION; MACROPHAGES; MULTIPLE SCLEROSIS; REGENERATIVE MEDICINE;

EID: 84886575052     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.13.73     Document Type: Review

References (21)

1. Shechter R, Schwartz M. Harnessing monocyte-Derived macrophages to control central nervous system pathologies: No longer if but how. J. Pathol. 229, 332-346 (2013
2. Wells JE, Hurlbert RJ, Fehlings MG, Yong VW. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126(Pt 7), 1628-1637 (2003
3. Sanchez Mejia RO, Ona VO, Li M, Friedlander RM. Minocycline reduces traumatic brain injury-mediated caspase 1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48(6), 1393-1399 (2001
4. Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann. Neurol. 52(1), 54-61 (2002
5. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14(9), 1142-1149 (2011
6. Cash E, Zhang Y, Rott O. Microglia present myelin antigens to T cells after phagocytosis of oligodendrocytes. Cell. Immunol. 147(1), 129-138 (1993
7. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. Cytotoxicity of microglia. Glia 7(1), 111-118 (1993
8. Li WW, Setzu A, Zhao C, Franklin RJ. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J. Neuroimmunol. 158(1-2), 58-66 (2005
9. Kotter MR, Setzu A, Sim FJ, Van Rooijen N, Franklin RJ. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35(3), 204-212 (2001
10. Miron VE, Boyd A, Zhao JW et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16(9), 1211-1218 (2013
11. Ruckh JM, Zhao JW, Shadrach JL et al. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10(1), 96-103 (2012
12. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29(43), 13435-13444 (2009
13. Mikita J, Dubourdieu-Cassagno N, Deloire MS et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 17(1), 2-15 (2011
14. Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J. Neuroimmune. Pharmacol. 8(4), 888-899 (2013
15. Voss EV, Skuljec J, Gudi V et al. Characterisation of microglia during de-And remyelination: Can they create a repair promoting environment? Neurobiol. Dis. 45(1), 519-528 (2012
16. Olah M, Amor S, Brouwer N et al. Identification of a microglia phenotype supportive of remyelination. Glia 60(2), 306-321 (2012
17. Letellier E, Kumar S, Sancho-Martinez I et al. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity. 32(2), 240-252 (2010
18. Popovich PG, Guan Z, Wei P, Huitinga I, Van Rooijen N, Stokes BT. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158(2), 351-365 (1999
19. Skihar V, Silva C, Chojnacki A et al. Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc. Natl Acad. Sci. USA 106(42), 17992-17997 (2009
20. Miron VE, Ludwin SK, Darlington PJ et al. Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. Am. J. Pathol. 176(6), 2682-2694 (2010
21. Durafourt BA, Lambert C, Johnson TA, Blain M, Bar-Or A, Antel JP. Differential responses of human microglia and blood-Derived myeloid cells to FTY720. J. Neuroimmunol. 230(1-2), 10-16 (2011